Beta Blocker Use and Total Knee Arthroplasty Among United States Medicare Beneficiaries
Pharmacoepidemiology and Drug Safety · 2026-05 · 35 (5)
DOI: 10.1002/pds.70387 ↗Kurz gefasst
Fachartikel in der Zeitschrift Pharmacoepidemiology and Drug Safety, online erschienen am 05.05.2026. Verfasst von Shailina Keshwani und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA. Hauptthemen laut MEDLINE: Arthroplasty, Replacement, Knee, Adrenergic beta-Antagonists, Osteoarthritis, Knee, Hypertension. Die Arbeit nennt 43 Literaturangaben.
Abstract (Originalsprache)
Background/Objectives Preclinical evidence suggests beta blockers may reduce cartilage degradation and delay knee osteoarthritis (OA) progression. While beta blockers are widely used in patients with hypertension, their potential role in preventing total knee arthroplasty (TKA) is unclear. Therefore, we assessed the association between beta blocker use and TKA in knee OA patients with hypertension.
Methods
We conducted a nested case–control study using a nationally representative sample of Medicare beneficiaries with newly diagnosed knee OA and prevalent hypertension from 2011 to 2020. Beneficiaries who underwent TKA were defined as cases, while those without TKA were defined as controls. Cases and controls were matched at a 1:4 ratio based on pre‐specified criteria using incident density sampling. We measured binary (exposed/unexposed) and cumulative exposure of beta blockers during 6 months before TKA using total standardized daily doses (TSDD) for each patient, categorized as unexposed (0), < 1–200, 201–400, 401–600, 601–900, > 900. Confounding was addressed using propensity score adjustment and stratification for the binary exposure and direct covariate adjustment for cumulative exposure in conditional logistic regression models.
Results
We included 30 338 beneficiaries with TKA and 106 145 matched controls. The mean age (SD) was 74.4 (5.5) years, and 67.1% were women in both groups. There was no significant association between beta blocker use and odds of TKA (adjusted OR [aOR] 1.01; 95% CI, 0.97–1.02) compared with unexposed individuals. Smilarly, no cumulative exposure category was associated with TKA risk (TSDD: < 1–200 [aOR, 1.01; 95% CI,0.97–1.04]; TSDD: 201–400 [aOR 1.00; 95% CI, 0.96–1.05]; TSDD: 401–600 [aOR, 1.02; 95% CI, 0.96–1.08]; TSDD: 601–900 [aOR 0.94; 95% CI, 0.87–1.00]; and, TSDD: > 900 [aOR 0.99; 95% CI, 0.91–1.08]), compared with the unexposed group.
Conclusion
We found no evidence to support that beta blocker exposure reduces the likelihood of TKA.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pharmaceutical Outcomes and Policy, College of Pharmacy, University of Florida, Gainesville, Florida, USA.
- Division of General Internal Medicine, School of Medicine, University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
- North Florida/South Georgia Veterans Health System; Geriatric Research Education and Clinical Center, Gainesville, Florida, USA.
- Department of Community Dentistry and Behavioral Science, College of Dentistry, University of Florida, Gainesville, Florida, USA.
- Center for Integrative Cardiovascular and Metabolic Disease, University of Florida, Gainesville, Florida, USA.
- Division of Cardiovascular Medicine, Department of Medicine, College of Medicine, University of Florida, Gainesville, Florida, USA.
ORCID-Profile: Shailina Keshwani, Haesuk Park, Wei-Hsuan Lo-Ciganic, Roger B Fillingim, Steven M Smith
Zitieren
APA
Keshwani, S., Park, H., Lo-Ciganic, W. H., Fillingim, R. B., & Smith, S. M. (2026). Beta Blocker Use and Total Knee Arthroplasty Among United States Medicare Beneficiaries. Pharmacoepidemiology and Drug Safety, 35(5). https://doi.org/10.1002/pds.70387
Vancouver
Keshwani S, Park H, Lo-Ciganic WH, Fillingim RB, Smith SM. Beta Blocker Use and Total Knee Arthroplasty Among United States Medicare Beneficiaries. Pharmacoepidemiology and Drug Safety. 2026;35(5). doi:10.1002/pds.70387
BibTeX
@article{Keshwani2026,
author = {Keshwani, Shailina and Park, Haesuk and Lo-Ciganic, Wei-Hsuan and Fillingim, Roger B and Smith, Steven M},
title = {Beta Blocker Use and Total Knee Arthroplasty Among United States Medicare Beneficiaries},
journal = {Pharmacoepidemiology and Drug Safety},
year = {2026},
volume = {35},
number = {5},
doi = {10.1002/pds.70387}
}
EUVIMED